Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

Multiple studies have demonstrated the importance of androgen receptor (AR) splice variants (SVs) in the progression of prostate cancer to the castration-resistant phenotype and their utility as a diagnostic. However, studies on AR expression in non-prostatic malignancies uncovered that AR-SVs are e...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Kimberley D. Katleba, Paramita M. Ghosh, Maria Mudryj
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Subjects:	androgen receptor splice variants malignancies pathologies development
Online Access:	https://www.mdpi.com/2227-9059/11/8/2215

Similar Items

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
by: Elisabeth A. Messner, et al.
Published: (2020-10-01)

Data of relative mRNA and protein abundances of androgen receptor splice variants in castration-resistant prostate cancer
by: Tianfang Ma, et al.
Published: (2021-02-01)

Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01)

Splice variants of androgen receptor and prostate cancer
by: Orazio Caffo, et al.
Published: (2016-05-01)

Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer
by: Tryambak Pratap Srivastava, et al.
Published: (2024-11-01)

Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer
by: Joanna Bialek, et al.
Published: (2021-07-01)

Therapeutic Approaches to Targeting Androgen Receptor Splice Variants
by: Violet A. Daniels, et al.
Published: (2024-01-01)

Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling
by: Ken-ichi Takayama
Published: (2019-04-01)

Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
by: Mercedes Marín-Aguilera, et al.
Published: (2020-01-01)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
by: Farhan Khan, et al.
Published: (2023-02-01)

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
by: Balaji Chandrasekaran, et al.
Published: (2023-03-01)

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
by: Neele Wüstmann, et al.
Published: (2023-04-01)

Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer
by: Xiaochuan Shan, et al.
Published: (2015-09-01)

Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer
by: Xiaochuan Shan, et al.
Published: (2018-04-01)

Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility
by: Neele Wüstmann, et al.
Published: (2025-08-01)

A novel androgen receptor gene splice site mutation induces aberrant mRNA splicing and internal in-frame deletion in androgen insensitivity syndrome
by: Baoqiong Liao, et al.
Published: (2026-04-01)

A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways
by: Yunlim Kim, et al.
Published: (2023-06-01)

Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?
by: Tryambak Pratap Srivastava, et al.
Published: (2025-01-01)

Abiraterone Rechallenge Based on Sequential Testing of Androgen Receptor Splice Variant 7 Expression in Circulating Tumor Cells: A Case Report
by: Naoya Nagaya, et al.
Published: (2020-04-01)

Alternative splicing in ovarian cancer
by: Liwei Wei, et al.
Published: (2024-10-01)

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
by: Jasper Van Goubergen, et al.
Published: (2025-02-01)

Knowledge structure and emerging trends of AR variants in prostate cancer: a bibliometric analysis based on CiteSpace and VOSviewer
by: Kai Yu, et al.
Published: (2023-07-01)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
by: Koji Kitamura, et al.
Published: (2021-04-01)

The role of alternative splicing in gastric cancer
by: Qichen Huang, et al.
Published: (2026-04-01)

The association of AR-V7 with resistance to Abiraterone in metastatic castration-resistant prostate cancer
by: Shuo Wang, et al.
Published: (2022-03-01)

The positive relationship between androgen receptor splice variant-7 expression and the risk of castration-resistant prostate cancer: A cumulative analysis
by: Shankun Zhao, et al.
Published: (2023-02-01)

Targeted splicing therapy: new strategies for colorectal cancer
by: Yifeng Zheng, et al.
Published: (2023-08-01)

Androgen receptor inhibitors in treating prostate cancer
by: Ryan N Cole, et al.
Published: (2025-03-01)

The role of 11-oxygenated androgens in prostate cancer
by: Gido Snaterse, et al.
Published: (2023-04-01)

Meta-analysis of Osteopontin splice variants in cancer
by: Yu An, et al.
Published: (2023-04-01)

Maximal androgen blockade for advanced prostate cancer
by: Rajiv Paul Mukha, et al.
Published: (2010-01-01)

Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
by: Mohammad Kamalabadi-Farahani, et al.
Published: (2022-09-01)

Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants
by: Demitria M. Vasilatis, et al.
Published: (2023-04-01)

Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer
by: Daniella Mattos, et al.
Published: (2024-09-01)

Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer
by: Robert D. Marek, et al.
Published: (2024-11-01)

Androgen receptor expression in hypospadias
by: Dhanvanth Rajesh Balaji, et al.
Published: (2020-01-01)

NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers
by: Juan Guzman, et al.
Published: (2024-03-01)

Investigation of cryptic JAG1 splice variants as a cause of Alagille syndrome and performance evaluation of splice predictor tools
by: Ernest Keefer-Jacques, et al.
Published: (2024-10-01)

Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer
by: Agus Rizal A. H. Hamid, et al.
Published: (2021-08-01)

Androgen insensitivity syndrome: Risk of malignancy and timing of surgery in a paediatric and adolescent population
by: Dragan Kravarusic, et al.
Published: (2011-01-01)